VIVANI MEDICAL INC (VANI)
US92854B1098 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.96M 99.50% | 6.9M -13.32% | 3.38M -51.01% | 2.635M -100.00% | 2.073M | 31.555M | 94.366M 199.05% | 208.27M 120.70% | ||||||||
| EBITDA YoY % growth | -28.15M 14.12% | -34.18M -21.42% | -30.19M 11.67% | -30.874M 58.56% | -28.66M 29.18% | -14.28M -135.44% | -20.4M -27.56% | -23.46M 11.83% | -23.46M | -23.46M | -38.76M -65.22% | -92.82M -139.47% | N/A | N/A | N/A | |
| EBIT YoY % growth | -28.61M 13.85% | -34.62M -21.01% | -30.59M 11.64% | -31.323M 58.58% | -29.133M 29.52% | -20.4M -137.85% | -28.467M -26.95% | -24.358M 9.67% | -27.052M -11.06% | -32.379M -19.69% | -38.259M -18.16% | -33.242M 13.11% | -664.02K 98.00% | 52.744M 8,043.13% | 147.25M 179.18% | |
| Operating Margin | -359.42% | -501.74% | -905.03% | -1,188.64% | -1,405.45% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -2.10% | 55.89% | 70.70% | |
| EPS YoY % growth | N/A 28.99% | N/A 5.45% | -6.54 48.62% | -8.39 -28.36% | -10.58 -26.04% | -0.27 97.49% | -0.54 -103.85% | -0.43 19.81% | -0.46 -7.06% | -0.55 -18.68% | -0.57 -3.70% | -0.91 -58.93% | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.11 6.50% | -0.11 6.50% | -0.10 -2.00% | -0.10 7.27% | -0.10 9.09% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.138M 1.27% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.11 15.38% | -0.12 | 0.01 | 6.22% |
| Q2 2024 Q2Q % growth | -0.10 23.08% | -0.12 | 0.02 | 18.30% |
| Q1 2024 Q2Q % growth | -0.12 | -0.12 | 0.00 | 1.96% |
| Q4 2023 Q2Q % growth | -0.12 | -0.14 | 0.02 | 15.97% |
| Q3 2023 Q2Q % growth | -0.13 -425.00% | -0.13 | 0.00 | 1.96% |
| Q2 2023 Q2Q % growth | -0.13 | -0.11 | -0.02 | -15.86% |
| Q2 2020 Q2Q % growth | -0.45 73.21% | -1.25 | 0.80 | 64.13% |
| Q1 2020 Q2Q % growth | -1.71 10.94% | -1.25 | -0.46 | -36.30% |
| Q4 2019 Q2Q % growth | -1.50 47.92% | -1.50 | 0.00 | -0.04% |
| Q3 2019 Q2Q % growth | -1.44 50.00% | -1.47 | 0.03 | 1.96% |
| Q2 2019 Q2Q % growth | -1.68 41.67% | -1.47 | -0.21 | -14.38% |
| Q1 2019 Q2Q % growth | -1.92 | -1.47 | -0.45 | -30.72% |
| Q4 2018 Q2Q % growth | -2.88 | -2.69 | -0.19 | -6.95% |
| Q3 2018 Q2Q % growth | -2.88 | -3.43 | 0.55 | 15.97% |
| Q2 2018 Q2Q % growth | -2.88 | -3.43 | 0.55 | 15.97% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2020 Q2Q % growth | -100.00% | % | ||
| Q2 2020 Q2Q % growth | -100.00% | 244.8K | -244.8K | -100.00% |
| Q1 2020 Q2Q % growth | -100.00% | 242.76K | -242.76K | -100.00% |
| Q4 2019 Q2Q % growth | 500K -71.75% | 477.36K | 22.64K | 4.74% |
| Q3 2019 Q2Q % growth | 470K -79.11% | 955.74K | -485.74K | -50.82% |
| Q2 2019 Q2Q % growth | 1.28M -32.98% | 462.06K | 817.94K | 177.02% |
| Q1 2019 Q2Q % growth | 1.13M 15.31% | 1.694M | -564K | -33.29% |
| Q4 2018 Q2Q % growth | 1.77M | 2.688M | -918K | -34.15% |
| Q3 2018 Q2Q % growth | 2.25M | 2.532M | -282K | -11.14% |
| Q2 2018 Q2Q % growth | 1.91M | 2.256M | -346K | -15.34% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 15.38% | 15.38% | 15% | 15% |
| Revenue | N/A | N/A | N/A | N/A |